[HTML][HTML] Obesity in adults: a clinical practice guideline
This guideline update reflects substantial advances in the epidemiology, determinants,
pathophysiology, assessment, prevention and treatment of obesity, and shifts the focus of obesity …
pathophysiology, assessment, prevention and treatment of obesity, and shifts the focus of obesity …
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
…, J Liutkus, D O'Keefe, R Padwal, TPP Ransom, R Tytus… - The Lancet, 2017 - thelancet.com
Background Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose
metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In …
metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In …
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
…, LA Nasi, L Oliveira, MJDEC CANTARELLI, R Tytus… - The Lancet, 2018 - thelancet.com
Background Patients with peripheral artery disease have an increased risk of cardiovascular
morbidity and mortality. Antiplatelet agents are widely used to reduce these complications. …
morbidity and mortality. Antiplatelet agents are widely used to reduce these complications. …
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
…, L OLIVEIRA, MJDEC CANTARELLI, R TYTUS… - The Lancet, 2018 - thelancet.com
Background Coronary artery disease is a major cause of morbidity and mortality worldwide,
and is a consequence of acute thrombotic events involving activation of platelets and …
and is a consequence of acute thrombotic events involving activation of platelets and …
Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient-and rater-blinded, randomized, controlled trial
The pharmacological treatment of depression consists of stages of trial and error, with less
than 40% of patients achieving remission during first medication trial. However, in a large, …
than 40% of patients achieving remission during first medication trial. However, in a large, …
Immunogenicity, safety, and tolerability of V114, a 15-valent pneumococcal conjugate vaccine, in immunocompetent adults aged 18–49 years with or without risk …
…, E Janczewska, FJ Pasquel, R Tytus… - Open Forum …, 2022 - academic.oup.com
Background Adults with certain medical and behavioral factors are at increased risk for
pneumococcal disease (PD). Sequential vaccination with 13-valent pneumococcal conjugate …
pneumococcal disease (PD). Sequential vaccination with 13-valent pneumococcal conjugate …
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
…, J Diez-Domingo, A Schilling, H Ariffin, R Tytus… - …, 2021 - publications.aap.org
METHODS: Girls received 2 (months 0 and 6 [0, 6]: n= 301; months 0 and 12 [0, 12]: n= 151)
or 3 doses (months 0, 2, and 6 [0, 2, 6]: n= 301); boys received 2 doses ([0, 6]: n= 301;[0, 12]: …
or 3 doses (months 0, 2, and 6 [0, 2, 6]: n= 301); boys received 2 doses ([0, 6]: n= 301;[0, 12]: …
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal …
…, E Janczewska, FJ Pasquel, R Tytus… - Human Vaccines & …, 2023 - Taylor & Francis
Immunocompetent adults with certain medical and behavioral factors are at increased risk
of pneumococcal disease. In some countries, sequential vaccination with 13-valent …
of pneumococcal disease. In some countries, sequential vaccination with 13-valent …
Impact of the COVID-19 pandemic on adults with type 2 diabetes care and clinical parameters in a primary care setting in Ontario, Canada: a cross-sectional study
AYY Cheng, S Harris, I Krawchenko, R Tytus… - Canadian journal of …, 2023 - Elsevier
Objectives Diabetes requires ongoing monitoring and care to prevent long-term adverse
health outcomes. In Canada, quarantine restrictions were put into place to address the …
health outcomes. In Canada, quarantine restrictions were put into place to address the …
L'obésité chez l'adulte: ligne directrice de pratique clinique
• L’obésité est une maladie chronique complexe, évolutive et récidivante fort répandue qui
se caractérise par une accumulation anormale ou excessive de graisses corporelles (…
se caractérise par une accumulation anormale ou excessive de graisses corporelles (…
